Taken together, our findings are the first to reveal that the antitumor activity of DHTS in vitro and in vivo against OXA-resistant CRC is associated with the expression of SHP2 and Wnt/β-catenin pathway protein. Here, PTPN11 is linked to colorectal carcinoma.